Design, Synthesis and Antibacterial Studies of 1,3,4‐Oxadiazole‐Fluoroquinolone Hybrids and Their Molecular Docking Studies
Open Access
- 6 December 2021
- journal article
- research article
- Published by Wiley in ChemistrySelect
- Vol. 6 (46) , 13209-13214
Abstract
A series of novel hybrids built on fluoroquinolone skeleton were synthesized by introducing 1,3,4‐oxadiazole derivatives to the C‐7 site of ciprofloxacin or norfloxacin. In vitro antibacterial evaluation showed that hybrids 4 b – d (5‐(hydroxyphenyl)‐1,3,4‐oxadiazol‐2‐yl substituted ciprofloxacin) were an increased activity against Staphylococcus aureus , with a minimum inhibitory concentration (MIC) of ≤0.125 μg/mL, four times superior to the parent drug. Hybrids 4 b – e ( 4 e , 5‐(4‐(trifluoromethyl) phenyl)‐1,3,4‐oxadiazol‐2‐yl substituted ciprofloxacin) also exhibited significant activity against methicillin‐resistant S. aureus (MRSA), resistant to the parent drug. All the hybrids demonstrated a bactericidal effect on standard bacteria with the MBC value not exceeding four times of their corresponding MIC values. In time‐killing assays, 4 c demonstrated a superior bactericidal action in eradicating S. aureus and E. coli within 2 h, respectively, equipotent to ciprofloxacin. In the molecular docking study, hybrids 4 c exhibited a high binding affinity for type IV topoisomerase with a minimum binding energy of −10.2 kcal/mol.Keywords
This publication has 34 references indexed in Scilit:
- Microwave assisted synthesis of some hybrid molecules derived from norfloxacin and investigation of their biological activitiesEuropean Journal of Medicinal Chemistry, 2013
- Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteriaEuropean Journal of Medicinal Chemistry, 2013
- Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agentEuropean Journal of Medicinal Chemistry, 2013
- Synthesis and antibacterial evaluation of novel analogs of fluoroquinolones annulated with 6-substituted-2-aminobenzothiazolesArabian Journal of Chemistry, 2011
- In Vitro 24-Hour Time-Kill Studies of Vancomycin and Linezolid in Combination versus Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2009
- Design, synthesis, antibacterial activity and physicochemical parameters of novel N-4-piperazinyl derivatives of norfloxacinBioorganic & Medicinal Chemistry, 2009
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug DiscoveryJournal of Medicinal Chemistry, 2008
- Clinical Relevance of Bacteriostatic versus Bactericidal Mechanisms of Action in the Treatment of Gram‐Positive Bacterial InfectionsClinical Infectious Diseases, 2004
- Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active EffluxScience, 1994
- Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding modelBiochemistry, 1989